Cargando…
Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer
Long noncoding RNAs (lncRNAs) have received increased attention as a new class of functional regulators involved in human carcinogenesis. HOXA cluster antisense RNA 2 (HOXA-AS2) is a 1048-bp lncRNA located between the HOXA3 and HOXA4 genes in the HOXA cluster that regulates gene expression at a tran...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294247/ https://www.ncbi.nlm.nih.gov/pubmed/28112720 http://dx.doi.org/10.1038/oncsis.2016.84 |
_version_ | 1782505205148942336 |
---|---|
author | Ding, J Xie, M Lian, Y Zhu, Y Peng, P Wang, J Wang, L Wang, K |
author_facet | Ding, J Xie, M Lian, Y Zhu, Y Peng, P Wang, J Wang, L Wang, K |
author_sort | Ding, J |
collection | PubMed |
description | Long noncoding RNAs (lncRNAs) have received increased attention as a new class of functional regulators involved in human carcinogenesis. HOXA cluster antisense RNA 2 (HOXA-AS2) is a 1048-bp lncRNA located between the HOXA3 and HOXA4 genes in the HOXA cluster that regulates gene expression at a transcription level. HOXA-AS2 is previously found to be overexpressed in gastric cancer (GC) and promotes GC cells proliferation. However, its potential role and molecular mechanism in colorectal cancer (CRC) are not known. Here, we identified that HOXA-AS2 is significantly upregulated in CRC tissue. In addition, increased HOXA-AS2 expression is associated with a larger tumor size and an advanced pathological stage in CRC patients. HOXA-AS2 knockdown significantly suppressed proliferation by blocking the G1/S transition and caused apoptosis of CRC cells in vitro and in vivo. The mechanistic investigations showed that HOXA-AS2 could interact with EZH2 (enhancer of zeste homolog 2), LSD1 (lysine specific demethylase 1) and recruit them to p21 (CDKN1A), KLF2 promoter regions to repress their transcription. Furthermore, the rescue experiments demonstrated that HOXA-AS2 oncogenic function is partly through regulating p21. In conclusion, our data suggest that HOXA-AS2 may function as an oncogene by modulating the multiple genes expression involved in CRC proliferation, and also provides a potential target for CRC therapy. |
format | Online Article Text |
id | pubmed-5294247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52942472017-02-14 Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer Ding, J Xie, M Lian, Y Zhu, Y Peng, P Wang, J Wang, L Wang, K Oncogenesis Original Article Long noncoding RNAs (lncRNAs) have received increased attention as a new class of functional regulators involved in human carcinogenesis. HOXA cluster antisense RNA 2 (HOXA-AS2) is a 1048-bp lncRNA located between the HOXA3 and HOXA4 genes in the HOXA cluster that regulates gene expression at a transcription level. HOXA-AS2 is previously found to be overexpressed in gastric cancer (GC) and promotes GC cells proliferation. However, its potential role and molecular mechanism in colorectal cancer (CRC) are not known. Here, we identified that HOXA-AS2 is significantly upregulated in CRC tissue. In addition, increased HOXA-AS2 expression is associated with a larger tumor size and an advanced pathological stage in CRC patients. HOXA-AS2 knockdown significantly suppressed proliferation by blocking the G1/S transition and caused apoptosis of CRC cells in vitro and in vivo. The mechanistic investigations showed that HOXA-AS2 could interact with EZH2 (enhancer of zeste homolog 2), LSD1 (lysine specific demethylase 1) and recruit them to p21 (CDKN1A), KLF2 promoter regions to repress their transcription. Furthermore, the rescue experiments demonstrated that HOXA-AS2 oncogenic function is partly through regulating p21. In conclusion, our data suggest that HOXA-AS2 may function as an oncogene by modulating the multiple genes expression involved in CRC proliferation, and also provides a potential target for CRC therapy. Nature Publishing Group 2017-01 2017-01-23 /pmc/articles/PMC5294247/ /pubmed/28112720 http://dx.doi.org/10.1038/oncsis.2016.84 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ Oncogenesis is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Ding, J Xie, M Lian, Y Zhu, Y Peng, P Wang, J Wang, L Wang, K Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer |
title | Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer |
title_full | Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer |
title_fullStr | Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer |
title_full_unstemmed | Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer |
title_short | Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer |
title_sort | long noncoding rna hoxa-as2 represses p21 and klf2 expression transcription by binding with ezh2, lsd1 in colorectal cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294247/ https://www.ncbi.nlm.nih.gov/pubmed/28112720 http://dx.doi.org/10.1038/oncsis.2016.84 |
work_keys_str_mv | AT dingj longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT xiem longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT liany longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT zhuy longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT pengp longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT wangj longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT wangl longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer AT wangk longnoncodingrnahoxaas2repressesp21andklf2expressiontranscriptionbybindingwithezh2lsd1incolorectalcancer |